In vivo selection using a cell-growth switch
Authors:
- 1 September 2000
- journal article
- letter
- Published by Springer Nature in Nature Genetics
- Vol. 26 (1) , 64-66
Abstract
A major obstacle to stem-cell gene therapy rests in the inability to deliver a gene into a therapeutically relevant fraction of stem cells1. One way to circumvent this obstacle is to use selection. Vectors containing two linked genes serve as the basis for selection, with one gene encoding a selectable product and the other, a therapeutic protein. Applying selection in vivo has the potential to bring a minor population of genetically corrected cells into the therapeutic range. But strategies for achieving in vivo selection have traditionally relied on genes that confer resistance to cytotoxic drugs2,3 and are encumbered by toxicity. Here we describe a new system for in vivo selection that uses a ‘cell-growth switch’, allowing a minor population of genetically modified cells to be inducibly amplified, thereby averting the risks associated with cytotoxic drugs. This system provides a general platform for conditionally expanding genetically modified cell populations in vivo, and may have widespread applications in gene and cell therapy.Keywords
This publication has 14 references indexed in Scilit:
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfectaNature Medicine, 1999
- In vivo selection of retrovirally transduced hematopoietic stem cellsNature Medicine, 1998
- A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cellsGene Therapy, 1997
- A proliferation switch for genetically modified cellsProceedings of the National Academy of Sciences, 1997
- Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.Proceedings of the National Academy of Sciences, 1994
- Controlling Signal Transduction with Synthetic LigandsScience, 1993
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Cloning of cDNAs for Fanconi's anaemia by functional complementationNature, 1992
- A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitorsCell, 1990